What Camp4 Therapeutics Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 5 | 14 |
| Sells | 6 | 6 |
| Total trades | 11 | 21 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 46,031 | 8,576,092 |
| Disposed | 593,613 | 593,613 |
| Net activity | −547,582 | +7,982,479 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gold Kelly | Chief Financial Officer | Aug 31 | Open-market buy · P | +10,000 | $3.96 | +$39.6K | 10,000 |
| Schwab Andrew J. | Director | Aug 27 | Open-market sale · S | −400,000 | $4.04 | −$1.62M | 2,033,270 |
| Schwab Andrew J. | Director | Aug 24 | Open-market sale · S | −10 | $4.50 | −$45 | 2,433,270 |
| Schwab Andrew J. | Director | Aug 21 | Open-market sale · S | −32,018 | $4.50 | −$144K | 2,433,280 |
| Schwab Andrew J. | Director | Aug 20 | Open-market sale · S | −114,700 | $4.54 | −$521K | 2,465,298 |
| Tardiff Daniel | Chief Scientific Officer | Aug 19 | Open-market sale · S | −1,738 | $4.76 | −$8.27K | 0 |
| Schwab Andrew J. | Director | Aug 19 | Open-market sale · S | −45,147 | $4.76 | −$215K | 2,579,998 |
| Maricich Yuri | Chief Medical Officer | Aug 03 | Open-market buy · P | +6,551 | $1.65 | +$10.8K | 12,611 |
| Mandel-Brehm Josh | Chief Executive Officer | Aug 03 | Open-market buy · P | +6,551 | $1.65 | +$10.8K | 284,968 |
| Gold Kelly | Chief Financial Officer | Aug 03 | Open-market buy · P | +6,551 | $1.65 | +$10.8K | 74,428 |
| Young Richard A | Director | Aug 03 | Open-market buy · P | +16,378 | $1.65 | +$27K | 186,388 |
| Nashat Amir | Director | Sep 11 | Open-market buy · P | +85,468 | $1.53 | +$131K | 197,661 |
| Nashat Amir | Director | Sep 11 | Open-market buy · P | +1,221,721 | $1.53 | +$1.87M | 2,825,500 |
| Polaris Management Co. VII, L.l.c. | 10% owner | Sep 11 | Open-market buy · P | +85,468 | $1.53 | +$131K | 197,661 |
| Polaris Management Co. VII, L.l.c. | 10% owner | Sep 11 | Open-market buy · P | +1,221,721 | $1.53 | +$1.87M | 2,825,500 |
| Young Richard A | Director | Sep 11 | Open-market buy · P | +15,151 | $1.65 | +$25K | 170,010 |
| Maricich Yuri | Chief Medical Officer | Sep 11 | Open-market buy · P | +6,060 | $1.65 | +$10K | 6,060 |
| Mandel-Brehm Josh | Chief Executive Officer | Sep 11 | Open-market buy · P | +6,060 | $1.65 | +$10K | 278,417 |
| Gold Kelly | Chief Financial Officer | Sep 11 | Open-market buy · P | +6,060 | $1.65 | +$10K | 67,877 |
| 5AM Partners VI, Llc | 10% owner | Sep 11 | Open-market buy · P | +2,941,176 | $1.53 | +$4.5M | 2,941,176 |
Loading...